Also, the blockade of CCR2 expression reduces tumor growth and inhibits the proliferation of cancer cells by influencing the PI3K/Akt and p38 MAPK signaling pathway in DLBCL (diffuse large B-cell lymphoma) [43]. Here, AKT1 is linked to cancer.